Publications- Papers

1. Natural Orifice Transluminal Endoscopic Surgery A Consensus statement on behalf of the ALSGBI, ACPGBI, BAUS, AUGIS, BOMSS, BSG, BSGE
Arulampalam THA, Patterson-Brown S, Morris AJ, Parker MC Ann R Coll Surg 2009;91:456-459

2. MRI for the assessment of locally advanced rectal cancer- there is a new windows of opportunity
Arulampalam THA, Sizer B, Lacey N, Motson RW Colorectal Disease 2009 in press

3. Locally advanced rectal cancer: histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy
Johnston DF, Lawrence KM, Sizer B, Arulampalam THA, Motson RW, Dove E, Lacey N Br J Radiol 2009;82(976):332-336

4. Manubriosternal Joint Dislocation: An Unusual Risk of Trampolining
Lyons I, Saha S, Arulampalam THA J Emergency Med (May 2009 epub ahead of print)

5. Training in laparoscopic colorectal surgery - experience of training in a specialist unit
Engledow AH, Arulampalam THA, Motson RW Ann R Coll Surg 2009 in press

6. The use of laparoscopic subtotal cholecystectomy for complicated cholelithiasis
Philips JA, Lawes DA, Cook AJ, Arulampalam THA, Zaborsky A, Menzies D, Motson RW
Surg Endosc. 2008 Jul;22(7):1697-700

7. Laparoscopic resection of diverticular fistulae - a ten year experience
Engeldow A, Arulampalam THA, Motson RW
Colorectal Disease 2007;2007:632-634

8. Serial MRI after chemoradiotherapy for rectal cancer can help to define a "window of opportunity" for laparoscopic surgery
Sizer B, Arulampalam THA, Lacey N, Austin, RCT, Motson RW
British Medical Journal 2006;333:808-809

9. MRC CLASICC trial
Arulampalam THA, Austin RCT, Motson RW
Lancet 2005;366:712

10. Laparoscopic common bile duct exploration - a feasible and safe operation for specialist registrars
Tutton M, Arulampalam THA, Motson RW
In preparation (2008)

11. FDG-PET for the pre-operative evaluation of colorectal liver metastases
Arulampalam THA, Francis DL, Visvikis D, Taylor I, Ell PJ.
European Journal of Surgical Oncology 2004;30:286-291

12. Potential impact of [18F] 3'-deoxy-3-fluorothymidine versus [18F] fluoro-2-deoxy-D-glucose in Positron Emission Tomography for colorectal cancer
Francis DL, Visvikis D, Costa DC, Arulampalam THA, Townsend C, Luthra SK, Taylor I, Ell PJ
European Journal of Nuclear Medicine and Molecular imaging 2003;30:988-994

13. Glucose Utilisation and Cell Proliferation in Colorectal Cancer
Visvikis, D, Francis, DL, Costa DC, Mulligan R, Townsend C, Arulampalam THA, Islam MS, Taylor I, Ell PJ
European Journal of Nuclear Medicine 2002;29:280

14. The clinical application of PET to the management of colorectal cancer
Arulampalam THA, Costa DC, Bomanji J, Ell PJ.
Quarterly Journal of Nuclear Medicine 2001;45:215-230

15. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer
Arulampalam THA, Costa DC, Visvikis D, Boulos PB, Taylor I, Ell PJ.
European Journal of Nuclear Medicine 2001;28:1758-1765

16. Asymptomatic patient with an increasing CEA
Arulampalam THA, Ledermann J, Costa DC.
Lancet Oncology 2001;2:172

17. Positron emission tomography and colorectal cancer
Arulampalam THA, Costa DC, Loizidou M, Visvikis D, Taylor I, Ell PJ.
British Journal of Surgery 2001;88:176-189

18. Laparoscopic cholecystectomy without operative cholangiogram: 2038 cases over a 5-year period in two district general hospitals
Taylor OM, Sedman PC, Jones BM, Royston CM, Arulampalam THA, Wellwood J.
Annals of the Royal College of Surgeons of England 1997;79:376-80.

19. Adenocarcinoma in Meckel's Cave
Tacconi L, Arulampalam THA, Johnston FG, Symon L.
Surgical Neurology 1995;44:553-3.

20. Intramedullary Spinal Cord Abscess
Tacconi L, Arulampalam THA, Johnston FG, Thomas DG.
Neurosurgery 1995;37:817-819.